AI assistant
Sending…
EXAGEN INC. — Director's Dealing 2022
Mar 2, 2022
33644_dirs_2022-03-02_6805dd3c-569f-42cb-9c59-acfe9c894067.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2022-03-01
Reporting Person: Rocca Fortunato R. (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-01 | Common Stock | F | 4322 | $7.12 | Disposed | 120678 | Direct |
Footnotes
F1: The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021.
More from EXAGEN INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11